AltaThera Pharmaceuticals Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
41

- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
7
AltaThera Pharmaceuticals General Information
Description
Developer of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult atrial fibrillation patients with effective treatments. The company's product focuses on critical care and alternative therapeutics for unmet medical needs and develops therapies for critical care patients and patients with rare disorders, enabling healthcare providers and hospitals to cure severe disorders improve patients' lives, and help optimize the delivery of quality care.
Contact Information
Website
www.altathera.comCorporate Office
- 311 South Wacker Drive
- Suite 6030
- Chicago, IL 60606
- United States
Corporate Office
- 311 South Wacker Drive
- Suite 6030
- Chicago, IL 60606
- United States
AltaThera Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
AltaThera Pharmaceuticals Comparisons
Industry
Financing
Details
AltaThera Pharmaceuticals Competitors (19)
One of AltaThera Pharmaceuticals’s 19 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
Pfizer Manufacturing Austria | Corporation | Orth An Der Donau, Austria | ||||
Lead Pharma | Venture Capital-Backed | Oss, Netherlands | ||||
Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
Altravax | Formerly VC-backed | Sunnyvale, CA |
AltaThera Pharmaceuticals Patents
AltaThera Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11610660-B1 | Antiarrhythmic drug dosing methods, medical devices, and systems | Active | 20-Aug-2021 | ||
US-20230075398-A1 | Antiarrhythmic drug dosing methods, medical devices, and systems | Active | 20-Aug-2021 | ||
US-20230255909-A1 | Methods of administering dofetilide | Pending | 20-Aug-2021 | ||
US-20230187049-A1 | Antiarrhythmic drug dosing methods and systems and prescription drug use related software | Pending | 20-Aug-2021 | ||
US-20230172883-A1 | Anti-arrhythmic compositions and methods | Pending | 20-Aug-2021 | A61K31/18 |
AltaThera Pharmaceuticals Signals
AltaThera Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
AltaThera Pharmaceuticals FAQs
-
When was AltaThera Pharmaceuticals founded?
AltaThera Pharmaceuticals was founded in 2012.
-
Where is AltaThera Pharmaceuticals headquartered?
AltaThera Pharmaceuticals is headquartered in Chicago, IL.
-
What is the size of AltaThera Pharmaceuticals?
AltaThera Pharmaceuticals has 41 total employees.
-
What industry is AltaThera Pharmaceuticals in?
AltaThera Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is AltaThera Pharmaceuticals a private or public company?
AltaThera Pharmaceuticals is a Private company.
-
What is AltaThera Pharmaceuticals’s current revenue?
The current revenue for AltaThera Pharmaceuticals is
. -
How much funding has AltaThera Pharmaceuticals raised over time?
AltaThera Pharmaceuticals has raised $7.61M.
-
Who are AltaThera Pharmaceuticals’s investors?
Thornapple River Capital and B. Riley Venture Capital have invested in AltaThera Pharmaceuticals.
-
Who are AltaThera Pharmaceuticals’s competitors?
Pfizer Pakistan, Pfizer Manufacturing Austria, Lead Pharma, Johnson&Johnson Innovative Medicine, and Altravax are some of the 19 competitors of AltaThera Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »